Based on the expression profiles of estrogen (ER) and progesterone (PR) receptors, as well as and human epidermal growth factor receptor 2 (HER2), this tumor is classified into different subtypes: luminal A, luminal B, HER2+, and basal. Here, ERBB2 is linked to neoplasm.